Patient-Friendly Real-Time Remote Monitoring System Receives FDA Clearance

Corsano Health's CardioWatch System, a patient-friendly multi-sensor bracelet, has received FDA clearance, opening doors for its European remote patient monitoring system in the US market. This advanced real-time monitoring solution collects vital signs data continuously, including pulse rate, SpO2, respiration rate, temperature, activity, spirometry, blood pressure, and weight. The system, already CE-MDR certified in Europe, has been pivotal in over 100 clinical trials, aiding in cardiovascular, oncology, and stress therapies. According to analyst Straits Research, RPM is driving growth in the global patient monitoring market, expected to reach $91.04 billion by 2031. The CardioWatch System integrates with third-party devices, addressing challenges like data management and patient participation, offering personalized treatment plans and improving patient outcomes.